161 related articles for article (PubMed ID: 25390640)
1. Preliminary investigation into a potential role for myostatin and its receptor (ActRIIB) in lean and obese horses and ponies.
Morrison PK; Bing C; Harris PA; Maltin CA; Grove-White D; Argo CM
PLoS One; 2014; 9(11):e112621. PubMed ID: 25390640
[TBL] [Abstract][Full Text] [Related]
2. Post-mortem stability of RNA in skeletal muscle and adipose tissue and the tissue-specific expression of myostatin, perilipin and associated factors in the horse.
Morrison PK; Bing C; Harris PA; Maltin CA; Grove-White D; Argo CM
PLoS One; 2014; 9(6):e100810. PubMed ID: 24956155
[TBL] [Abstract][Full Text] [Related]
3. Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice.
Allen DL; Cleary AS; Speaker KJ; Lindsay SF; Uyenishi J; Reed JM; Madden MC; Mehan RS
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E918-27. PubMed ID: 18334608
[TBL] [Abstract][Full Text] [Related]
4. Post-exercise changes in myostatin and actRIIB expression in obese insulin-resistant rats.
Bueno PG; Bassi D; Contrera DG; Carnielli HM; Silva RN; Nonaka KO; Selistre-de-Araújo HS; Leal AM
Mol Cell Endocrinol; 2011 Jun; 339(1-2):159-64. PubMed ID: 21539891
[TBL] [Abstract][Full Text] [Related]
5. Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy.
Morvan F; Rondeau JM; Zou C; Minetti G; Scheufler C; Scharenberg M; Jacobi C; Brebbia P; Ritter V; Toussaint G; Koelbing C; Leber X; Schilb A; Witte F; Lehmann S; Koch E; Geisse S; Glass DJ; Lach-Trifilieff E
Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12448-12453. PubMed ID: 29109273
[TBL] [Abstract][Full Text] [Related]
6. The role of myostatin and activin receptor IIB in the regulation of unloading-induced myofiber type-specific skeletal muscle atrophy.
Babcock LW; Knoblauch M; Clarke MS
J Appl Physiol (1985); 2015 Sep; 119(6):633-42. PubMed ID: 26205544
[TBL] [Abstract][Full Text] [Related]
7. Interference with myostatin/ActRIIB signaling as a therapeutic strategy for Duchenne muscular dystrophy.
Amthor H; Hoogaars WM
Curr Gene Ther; 2012 Jun; 12(3):245-59. PubMed ID: 22554312
[TBL] [Abstract][Full Text] [Related]
8. Increased secretion and expression of myostatin in skeletal muscle from extremely obese women.
Hittel DS; Berggren JR; Shearer J; Boyle K; Houmard JA
Diabetes; 2009 Jan; 58(1):30-8. PubMed ID: 18835929
[TBL] [Abstract][Full Text] [Related]
9. The effects of a soluble activin type IIB receptor on obesity and insulin sensitivity.
Akpan I; Goncalves MD; Dhir R; Yin X; Pistilli EE; Bogdanovich S; Khurana TS; Ucran J; Lachey J; Ahima RS
Int J Obes (Lond); 2009 Nov; 33(11):1265-73. PubMed ID: 19668253
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling of skeletal muscles treated with a soluble activin type IIB receptor.
Rahimov F; King OD; Warsing LC; Powell RE; Emerson CP; Kunkel LM; Wagner KR
Physiol Genomics; 2011 Apr; 43(8):398-407. PubMed ID: 21266502
[TBL] [Abstract][Full Text] [Related]
11. Co-Administration of Myostatin-Targeting siRNA and ActRIIB-Fc Fusion Protein Increases Masseter Muscle Mass and Fiber Size.
Bayarsaikhan O; Kawai N; Mori H; Kinouchi N; Nikawa T; Tanaka E
J Nutr Sci Vitaminol (Tokyo); 2017; 63(4):244-248. PubMed ID: 28978871
[TBL] [Abstract][Full Text] [Related]
12. The effects of an ActRIIb receptor Fc fusion protein ligand trap in juvenile simian immunodeficiency virus-infected rhesus macaques.
O'Connell KE; Guo W; Serra C; Beck M; Wachtman L; Hoggatt A; Xia D; Pearson C; Knight H; O'Connell M; Miller AD; Westmoreland SV; Bhasin S
FASEB J; 2015 Apr; 29(4):1165-75. PubMed ID: 25466897
[TBL] [Abstract][Full Text] [Related]
13. Serum Myostatin is Upregulated in Obesity and Correlates with Insulin Resistance in Humans.
Amor M; Itariu BK; Moreno-Viedma V; Keindl M; Jürets A; Prager G; Langer F; Grablowitz V; Zeyda M; Stulnig TM
Exp Clin Endocrinol Diabetes; 2019 Sep; 127(8):550-556. PubMed ID: 30075479
[TBL] [Abstract][Full Text] [Related]
14. Reduced Circulating GDF11 Is Unlikely Responsible for Age-Dependent Changes in Mouse Heart, Muscle, and Brain.
Rodgers BD; Eldridge JA
Endocrinology; 2015 Nov; 156(11):3885-8. PubMed ID: 26372181
[TBL] [Abstract][Full Text] [Related]
15. Soluble activin receptor type IIB treatment does not cause fat loss in mice with diet-induced obesity.
McPherron AC; Guo T; Wang Q; Portas J
Diabetes Obes Metab; 2012 Mar; 14(3):279-82. PubMed ID: 22023380
[TBL] [Abstract][Full Text] [Related]
16. A soluble activin type IIB receptor improves function in a mouse model of amyotrophic lateral sclerosis.
Morrison BM; Lachey JL; Warsing LC; Ting BL; Pullen AE; Underwood KW; Kumar R; Sako D; Grinberg A; Wong V; Colantuoni E; Seehra JS; Wagner KR
Exp Neurol; 2009 Jun; 217(2):258-68. PubMed ID: 19285073
[TBL] [Abstract][Full Text] [Related]
17. Mice overexpressing growth hormone exhibit increased skeletal muscle myostatin and MuRF1 with attenuation of muscle mass.
Consitt LA; Saneda A; Saxena G; List EO; Kopchick JJ
Skelet Muscle; 2017 Sep; 7(1):17. PubMed ID: 28870245
[TBL] [Abstract][Full Text] [Related]
18. TGFβ Superfamily Members Mediate Androgen Deprivation Therapy-Induced Obese Frailty in Male Mice.
Pan C; Singh S; Sahasrabudhe DM; Chakkalakal JV; Krolewski JJ; Nastiuk KL
Endocrinology; 2016 Nov; 157(11):4461-4472. PubMed ID: 27611336
[TBL] [Abstract][Full Text] [Related]
19. A soluble activin receptor type IIb prevents the effects of androgen deprivation on body composition and bone health.
Koncarevic A; Cornwall-Brady M; Pullen A; Davies M; Sako D; Liu J; Kumar R; Tomkinson K; Baker T; Umiker B; Monnell T; Grinberg AV; Liharska K; Underwood KW; Ucran JA; Howard E; Barberio J; Spaits M; Pearsall S; Seehra J; Lachey J
Endocrinology; 2010 Sep; 151(9):4289-300. PubMed ID: 20573726
[TBL] [Abstract][Full Text] [Related]
20. The relationship between changes in serum myostatin and adiponectin levels in patients with obesity undergoing a weight loss program.
Takao N; Kurose S; Miyauchi T; Onishi K; Tamanoi A; Tsuyuguchi R; Fujii A; Yoshiuchi S; Takahashi K; Tsutsumi H; Kimura Y
BMC Endocr Disord; 2021 Jul; 21(1):147. PubMed ID: 34233657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
